Sign in
8-K

Current Report

Xeris Biopharma Holdings, Inc. Filed Acc 0001867096-24-000102

Executive or director change · Shareholder vote results

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing